A Study of Ivonescimab in People With Leiomyosarcoma
Clinical trial NCT07516925 · RECRUITING
Trial details
- NCT number
- NCT07516925
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2029-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.